Status:

COMPLETED

Validation of Uncalibrated Cardiac Output Measurement With LiDCOrapid in the Resuscitation of Critically Ill Patients With Septic Shock: A Prospective Cross-sectional Study.

Lead Sponsor:

Cairo University

Conditions:

Cardiac Output, LIDCO Rapid, Septic Shock

Eligibility:

All Genders

18+ years

Brief Summary

Transthoracic echocardiography (TTE) has been used as a reference technique for CO measurement and its accuracy has been adequate for many clinical uses. TTE is painless, safe and non-invasive. Some d...

Detailed Description

Obtaining a patient's cardiac output (CO) could contribute to optimized, safe hemodynamic control. Accurate CO measurements can serve as a guide for resuscitation therapy, catecholamine use, different...

Eligibility Criteria

Inclusion

  • Age \> 18 years.
  • Patients admitted to ICU with septic shock

Exclusion

  • Patients with poor Echo window.
  • If they presented with a history of heart failure, valvular disease or arrhythmias.

Key Trial Info

Start Date :

December 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2021

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04705493

Start Date

December 1 2019

End Date

July 1 2021

Last Update

August 16 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kasr El Ainy Shcool of Medicine

Cairo, Egypt, 11211

Validation of Uncalibrated Cardiac Output Measurement With LiDCOrapid in the Resuscitation of Critically Ill Patients With Septic Shock: A Prospective Cross-sectional Study. | DecenTrialz